Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23326,81,1.03 [0.78-1.36],0.8166076532461601
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23820,124,1.08 [0.88-1.33],0.4680376807781429
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23610,866,1.06 [0.98-1.15],0.166478223587459
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,23844,264,1.14 [1.00-1.30],0.0569500261385335
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23161,2357,1.04 [0.99-1.09],0.1595851738970924
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23377,1763,1.03 [0.97-1.09],0.3477800644558576
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23668,842,0.99 [0.91-1.09],0.8868134527914181
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23773,36,1.22 [0.87-1.70],0.2415048845436759
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22758,550,1.09 [0.99-1.20],0.0918386791275387
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21982,524,1.09 [0.99-1.21],0.0865467560296144
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,22206,148,1.16 [0.97-1.39],0.0981307405854356
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17735,1032,1.07 [1.00-1.16],0.0669660599292558
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,22008,245,1.12 [0.97-1.29],0.133162484504442
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23808,982,1.02 [0.95-1.11],0.5538239488434904
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Mycoses,23900,320,1.13 [0.99-1.27],0.0607645629575824
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23268,524,1.04 [0.93-1.16],0.4759866562998268
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23847,602,1.07 [0.97-1.18],0.1496670218316312
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22952,126,1.08 [0.88-1.33],0.4516215627476544
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23939,25,1.22 [0.81-1.83],0.3330857669877322
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23776,531,1.10 [0.99-1.21],0.072197882061797
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23801,64,0.92 [0.64-1.30],0.6292200470803166
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23850,151,1.04 [0.86-1.27],0.6773675322779033
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23836,137,1.05 [0.85-1.28],0.6674161616958421
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,23042,298,1.05 [0.91-1.21],0.5134035861863067
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22946,202,1.07 [0.91-1.27],0.4051371842527387
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22890,64,1.25 [0.98-1.59],0.0760264530433534
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23912,45,0.85 [0.54-1.34],0.4811297560170202
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23885,112,0.98 [0.76-1.25],0.8511464727773449
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Viral warts,23812,39,1.07 [0.73-1.56],0.7316854095689496
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23815,42,0.76 [0.46-1.26],0.2924203291615645
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign lipomatous neoplasm,23692,269,1.01 [0.86-1.17],0.9385492505247158
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23864,62,1.14 [0.87-1.50],0.353453779228556
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23840,67,1.20 [0.94-1.54],0.1476068806738369
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10695,37,0.85 [0.51-1.42],0.5437294639869938
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23763,997,1.10 [1.02-1.18],0.0115209548385112
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm of meninges,23928,42,0.63 [0.35-1.14],0.1249656393046593
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23907,46,0.97 [0.66-1.43],0.8920551691492765
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23918,78,1.10 [0.85-1.43],0.4507369324577914
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm of ovary,13188,85,1.06 [0.82-1.36],0.6599805042937633
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23930,238,1.04 [0.89-1.22],0.624429697962303
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm: Caecum,23928,178,0.97 [0.80-1.19],0.7981435253543419
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23872,44,0.62 [0.35-1.12],0.1151668551928728
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,23933,149,1.18 [0.99-1.40],0.0600400893889187
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm: Rectum,23901,246,1.23 [1.08-1.39],0.0014917313976089
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23870,462,1.09 [0.98-1.22],0.1000379904635437
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23931,263,1.17 [1.02-1.33],0.020995052283389
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Carcinoma in situ of breast,11312,75,0.92 [0.67-1.26],0.5913376694494992
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",11351,84,0.81 [0.58-1.14],0.2254331930265405
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",20656,27,1.04 [0.64-1.67],0.8793084132439138
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",20662,33,1.12 [0.75-1.67],0.5813139370514628
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23898,96,1.20 [0.98-1.47],0.0803639738235906
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Haemangioma, any site",23898,94,1.17 [0.95-1.45],0.1377224278758869
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Leiomyoma of uterus,12629,354,1.06 [0.94-1.20],0.3247362593072811
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Lung cancer and mesothelioma,17751,157,1.03 [0.85-1.26],0.7481002156945952
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Lymphoid leukaemia,20655,26,1.12 [0.72-1.74],0.6181302734695968
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",20756,127,0.99 [0.79-1.24],0.9233969104486976
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",20705,76,1.02 [0.77-1.37],0.8745270426061821
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",11399,68,0.92 [0.66-1.29],0.6414659216084659
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",20673,44,0.98 [0.66-1.46],0.9208046955235204
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",20678,49,0.71 [0.43-1.18],0.1880359907095816
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",20691,62,1.01 [0.73-1.40],0.9517167291316716
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",11379,48,1.00 [0.71-1.43],0.9799496101879608
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",20677,48,1.06 [0.75-1.51],0.7439364539387708
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9644,346,1.00 [0.87-1.15],0.9816247826418296
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",20713,84,1.08 [0.84-1.40],0.543589646570334
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",20676,47,1.00 [0.69-1.46],0.990072742670066
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,20684,55,1.00 [0.71-1.41],0.9978234406466724
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Melanocytic naevi,23733,187,1.03 [0.87-1.23],0.7189322131819855
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Melanocytic naevi of trunk,23897,85,0.90 [0.66-1.22],0.4956225617492972
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Melanoma in situ,20638,38,1.05 [0.71-1.55],0.819436480311895
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",20681,52,1.10 [0.80-1.52],0.55334550922042
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",20725,96,1.06 [0.82-1.35],0.6633566811989913
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",20734,105,1.01 [0.79-1.29],0.9308567068977832
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",20683,54,0.95 [0.65-1.37],0.7688740929326563
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Other benign neoplasms of skin,23779,128,0.86 [0.66-1.12],0.2635886914491092
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",21178,549,1.01 [0.91-1.13],0.8225814917226274
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",21206,577,1.03 [0.93-1.14],0.6239287406998808
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23690,263,1.07 [0.93-1.23],0.3483569722275562
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22708,41,1.13 [0.80-1.61],0.4914052128470423
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23492,65,0.90 [0.63-1.29],0.5658324715518852
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23239,1924,1.03 [0.98-1.09],0.2822449246503274
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22934,20,1.21 [0.78-1.90],0.3953526910535314
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23632,28,1.00 [0.61-1.63],0.9946535660901832
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23546,879,1.08 [1.00-1.17],0.0434869613044697
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23546,879,1.08 [1.00-1.17],0.0434869613044697
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22716,49,1.44 [1.16-1.80],0.0011252711102214
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23700,786,1.04 [0.95-1.13],0.3979217445086224
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23696,92,0.92 [0.68-1.23],0.5536386776011915
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23475,48,1.09 [0.79-1.52],0.59541612715151
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23465,38,1.08 [0.74-1.57],0.7048770816954029
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23771,167,1.06 [0.88-1.27],0.5604904200663734
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23871,58,1.18 [0.91-1.54],0.2155291129267155
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23748,144,1.06 [0.87-1.29],0.5693427902269457
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22976,62,0.88 [0.61-1.27],0.4876046548114047
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,20544,173,0.98 [0.80-1.21],0.8774404557090024
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22239,105,1.05 [0.82-1.34],0.680901520371108
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22256,122,1.20 [0.99-1.46],0.062655735119166
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,20402,31,0.86 [0.50-1.47],0.5884724462218264
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22208,63,1.22 [0.95-1.57],0.1149451411626998
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21905,123,0.98 [0.78-1.25],0.8873750208076823
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23814,139,1.14 [0.95-1.38],0.162548284985971
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23721,46,1.33 [1.03-1.72],0.0299600925348788
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,23706,31,0.90 [0.54-1.51],0.6907313089290089
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23588,1443,1.01 [0.94-1.08],0.7946940354124251
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21439,1402,1.01 [0.94-1.08],0.7838232585114132
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",20405,34,0.35 [0.15-0.84],0.0187133995408213
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22510,51,1.08 [0.78-1.50],0.637772694788717
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,20531,160,1.21 [1.03-1.42],0.0177348545473746
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,20424,53,1.03 [0.73-1.46],0.8555587665480698
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22450,2079,1.02 [0.97-1.08],0.4460805368486349
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,20479,108,1.14 [0.93-1.41],0.2023698981917071
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,20707,336,1.13 [1.00-1.27],0.0532713052855969
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23854,225,0.96 [0.81-1.15],0.6772191823547129
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23716,87,0.89 [0.65-1.21],0.4484619372448475
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,20461,90,0.93 [0.69-1.25],0.6226743541596289
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",20405,34,1.17 [0.81-1.68],0.4054978671068343
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23568,1109,1.10 [1.03-1.18],0.0037984530106096
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,20481,110,1.02 [0.80-1.30],0.8522657039749026
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,20501,130,1.17 [0.96-1.41],0.1165566477428002
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",20717,346,0.91 [0.77-1.06],0.2221343731127746
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,20424,53,0.91 [0.61-1.36],0.6467106112459144
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23711,82,0.88 [0.64-1.21],0.4257461533105109
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,20630,259,1.00 [0.85-1.17],0.994701882891233
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,20637,266,1.02 [0.87-1.19],0.8308537417789397
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21833,51,1.01 [0.71-1.44],0.9596547584805308
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23330,2959,1.02 [0.97-1.07],0.4236178073454569
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22485,26,1.18 [0.80-1.74],0.4132884034591531
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22511,52,1.02 [0.73-1.43],0.9175522503860676
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23779,1681,1.03 [0.97-1.10],0.3241803260149509
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23782,1678,1.03 [0.97-1.10],0.3163711635795869
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22490,31,0.72 [0.39-1.34],0.3050155546361358
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23661,1067,1.06 [0.98-1.14],0.1396059622146358
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21138,767,1.02 [0.93-1.12],0.6140668021916651
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23931,110,1.10 [0.88-1.37],0.3847518013920186
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,23704,29,1.19 [0.80-1.75],0.3915124914976819
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22672,78,0.98 [0.73-1.32],0.9151410036841808
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22691,97,1.05 [0.82-1.35],0.6861993328937501
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",20480,109,1.11 [0.89-1.37],0.3595447559717867
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22374,106,1.09 [0.87-1.37],0.4479418018268204
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1489,57,0.98 [0.67-1.42],0.90573728444294
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1585,165,0.99 [0.80-1.22],0.9041190152181352
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22304,36,1.10 [0.72-1.68],0.6457398354972986
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1463,31,1.11 [0.75-1.64],0.6112009733846833
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23580,1312,1.00 [0.93-1.08],0.9260569913542824
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23735,60,0.91 [0.63-1.32],0.6258756767669673
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,22026,244,1.04 [0.89-1.21],0.5969165750421858
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20718,347,0.90 [0.77-1.05],0.1711161563412108
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23860,149,1.22 [1.04-1.44],0.0144231594436565
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23283,47,1.09 [0.77-1.53],0.6341328614506968
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Angina pectoris,22831,700,0.94 [0.85-1.04],0.2375149780126499
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,23326,90,1.21 [0.97-1.49],0.0895908232005948
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23266,30,1.37 [0.99-1.90],0.053897709950471
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23332,96,1.13 [0.90-1.42],0.2787850793435005
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16983,783,1.03 [0.95-1.13],0.4440117315238853
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,AV-block,21795,158,1.08 [0.89-1.30],0.4486437978108732
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23909,225,1.05 [0.89-1.23],0.5433609603320058
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,16294,94,1.11 [0.88-1.41],0.3822772629174932
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21748,111,1.15 [0.93-1.41],0.2010695187990081
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",21706,69,1.10 [0.84-1.45],0.4780722653153086
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23941,15,0.89 [0.42-1.87],0.7518317062698996
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Conduction disorders,22100,463,1.00 [0.89-1.13],0.9823946753139694
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23290,1169,0.92 [0.84-1.00],0.041889167818739
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22224,5246,1.02 [0.98-1.05],0.382004310256654
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22936,157,1.25 [1.07-1.46],0.0044420510303966
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Endocarditis,21678,41,0.81 [0.49-1.34],0.4147590396709693
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23832,451,0.99 [0.88-1.12],0.8902775762289985
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Hypertension,22724,4268,1.02 [0.99-1.06],0.2312633852208175
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",22733,4277,1.02 [0.98-1.06],0.2532288324524497
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23783,48,1.44 [1.15-1.81],0.0014938878137751
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18532,76,1.02 [0.77-1.35],0.8981652856738539
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18498,42,1.23 [0.92-1.65],0.1646327138517098
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Hypotension,23850,597,1.00 [0.90-1.11],0.9367570333404122
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23477,54,0.81 [0.53-1.24],0.3385885443685889
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23438,1307,0.94 [0.88-1.02],0.1367370415862314
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23742,269,1.01 [0.87-1.18],0.8821545760328785
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,21819,182,0.99 [0.81-1.20],0.8987875122535979
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23717,529,0.86 [0.76-0.98],0.0270967128970983
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22561,430,0.82 [0.71-0.96],0.0127105212091695
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23892,105,0.58 [0.38-0.86],0.0075963694950003
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23926,184,0.93 [0.75-1.14],0.4735522982113035
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,22809,30,0.98 [0.60-1.60],0.931419926404186
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other aneurysm,23277,41,0.64 [0.35-1.16],0.1423547702171963
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,21858,221,1.09 [0.93-1.27],0.2913098966517994
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23297,61,1.12 [0.84-1.49],0.4542164652763829
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23365,129,0.96 [0.76-1.22],0.7405997618830611
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,21749,112,0.97 [0.75-1.24],0.7979484055668595
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,22840,61,1.24 [0.97-1.60],0.0914659172149459
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22824,45,1.31 [1.00-1.72],0.0481864201197496
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23265,32,1.18 [0.81-1.72],0.3869076285595746
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22859,80,1.24 [1.00-1.55],0.0498774739238544
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,22144,507,1.02 [0.91-1.14],0.7425301753723332
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23293,40,0.90 [0.57-1.42],0.6501428632535777
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23540,304,1.04 [0.90-1.20],0.580409070836982
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23544,135,1.08 [0.88-1.32],0.4630000576303611
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23436,203,0.99 [0.82-1.19],0.9063898828248966
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16412,212,0.98 [0.81-1.18],0.8169223442097573
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23395,180,1.06 [0.88-1.27],0.5343808821872782
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22994,215,1.16 [1.00-1.34],0.0512082345871852
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23700,291,0.92 [0.78-1.09],0.3419598450201488
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23902,279,0.93 [0.78-1.10],0.3720077896686451
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,21784,147,0.90 [0.71-1.14],0.3909659281465221
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23541,132,1.09 [0.89-1.33],0.4104695941622884
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,23333,100,0.87 [0.65-1.17],0.3635793222858593
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23735,312,0.96 [0.83-1.12],0.6328123967421483
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23712,345,0.99 [0.86-1.14],0.8754938220962151
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23456,47,1.04 [0.74-1.47],0.8171611824280272
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23285,50,1.01 [0.71-1.45],0.9390340915342053
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23590,117,1.03 [0.82-1.29],0.8181237745599979
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23348,160,0.97 [0.78-1.20],0.7606364751085115
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Varicose veins,23049,270,1.07 [0.92-1.23],0.3792048050872564
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23245,42,1.08 [0.76-1.54],0.6795737983546767
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23786,452,1.03 [0.91-1.15],0.656785618966075
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23797,322,1.04 [0.91-1.19],0.5542483248618624
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21299,1220,1.05 [0.98-1.12],0.1745240436234149
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,Any mental disorder,23281,3202,1.01 [0.96-1.05],0.8202120974563947
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23743,376,1.07 [0.95-1.21],0.2782160839029487
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21549,1470,1.01 [0.95-1.08],0.7357117322384354
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20156,77,0.84 [0.59-1.19],0.3169416031346633
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,Smoking dependency,23467,1346,0.99 [0.93-1.06],0.851125426723371
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21624,1545,0.99 [0.93-1.06],0.759773432100487
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,Vascular dementia,23841,16,0.82 [0.37-1.85],0.6383791783565043
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Alzheimer disease,23940,64,1.22 [0.95-1.56],0.1192785802363062
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Bell's palsy,22479,65,1.20 [0.93-1.55],0.1590251159858827
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22839,425,1.00 [0.89-1.13],0.9537444070714728
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Cerebral cysts,23627,171,1.12 [0.95-1.33],0.1810530561761831
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23862,191,0.82 [0.65-1.03],0.0826025395493152
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23807,21,0.99 [0.56-1.73],0.9693356020256628
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23929,49,1.03 [0.72-1.47],0.8689559260385982
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23505,49,0.97 [0.66-1.42],0.8717710601171251
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Epilepsy,22587,227,1.02 [0.86-1.20],0.8269361790993127
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23514,1154,0.97 [0.90-1.05],0.5084004969845899
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23913,166,1.04 [0.86-1.26],0.7140422600516103
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23500,1449,1.01 [0.94-1.07],0.8742378932169464
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,23617,48,1.04 [0.73-1.48],0.8284291521673144
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Hemiplegia,23813,142,0.85 [0.66-1.10],0.2254157466135927
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Hydrocephalus,23498,42,0.85 [0.53-1.36],0.5092011252507158
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23919,60,0.74 [0.47-1.15],0.1798311726910731
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22483,69,1.04 [0.78-1.38],0.7893236746509267
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22485,71,1.20 [0.95-1.53],0.1305727225679719
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Memory loss,23811,66,1.05 [0.78-1.41],0.7572718778291638
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Migraine,22722,362,0.91 [0.79-1.05],0.2128105352433779
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23863,328,0.94 [0.81-1.09],0.3793796249917358
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Motor neuron disease,17404,91,0.77 [0.54-1.10],0.1529645498669307
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23750,132,0.84 [0.65-1.09],0.1807910294858128
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23411,997,1.03 [0.95-1.11],0.5212550820255402
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Neurological diseases,22671,2641,1.03 [0.98-1.08],0.2386187397156483
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23855,69,1.14 [0.87-1.48],0.3348376670887346
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22757,343,1.05 [0.92-1.20],0.4527076572451379
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23879,200,1.03 [0.86-1.23],0.7761207873423213
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19972,281,1.02 [0.88-1.18],0.8224249875540395
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23508,52,0.95 [0.65-1.39],0.7974834607622254
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23559,103,0.94 [0.72-1.24],0.6643410607912628
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23817,70,1.11 [0.85-1.46],0.4265423624352715
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22497,83,1.10 [0.86-1.42],0.4493682235224374
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other headache syndromes,22413,53,0.79 [0.51-1.23],0.2915558004588814
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other neurological diseases,23837,381,1.05 [0.93-1.19],0.3966247943720836
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other sleep disorders,22871,511,1.00 [0.89-1.12],0.9532748451173616
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Parkinson's disease,23927,75,0.88 [0.62-1.24],0.4653388867980182
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23509,53,1.00 [0.71-1.40],0.9911703659134576
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,23939,32,1.29 [0.94-1.78],0.1179163531575483
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Sleep apnoea,23725,444,1.03 [0.91-1.16],0.6143649981444161
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23711,32,0.89 [0.53-1.50],0.6685765387584939
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23924,115,0.83 [0.62-1.11],0.2093525336571977
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22440,26,0.51 [0.22-1.18],0.1157820223970305
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23940,65,1.21 [0.94-1.55],0.1375616837964252
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23829,15,0.69 [0.26-1.82],0.4513128938545064
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23524,35,0.70 [0.38-1.29],0.2500529171155063
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23626,180,0.92 [0.74-1.13],0.4182945399595241
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23867,169,1.02 [0.84-1.25],0.8247425339039857
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23282,33,1.08 [0.72-1.63],0.6996028857574714
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23316,67,1.03 [0.77-1.39],0.8435330276354518
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23857,26,1.21 [0.82-1.78],0.3399279720495215
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23773,53,0.91 [0.61-1.35],0.6283817639095555
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1465,33,1.09 [0.74-1.62],0.658058288171811
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1734,68,0.93 [0.66-1.30],0.6708903649487676
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23559,70,0.98 [0.72-1.34],0.9015970395591568
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23832,538,1.01 [0.90-1.13],0.8756672234336036
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23667,418,1.06 [0.94-1.19],0.3656899812315167
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23372,123,1.09 [0.89-1.34],0.4230245898542261
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23857,411,0.92 [0.81-1.06],0.2585697450587164
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23933,50,1.01 [0.70-1.44],0.9656994867540856
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23790,344,0.89 [0.76-1.04],0.15297548302985
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23905,185,1.04 [0.86-1.24],0.7018951581717315
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23882,119,0.90 [0.69-1.17],0.4262481412187875
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23264,15,1.31 [0.81-2.11],0.2729094618149438
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23275,26,0.90 [0.51-1.59],0.7201318490656221
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23279,30,0.78 [0.43-1.41],0.4044389974957935
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23898,335,1.17 [1.04-1.31],0.0110056303979674
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23647,84,1.03 [0.79-1.36],0.8142645208276795
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23467,21,0.81 [0.41-1.60],0.5480197736352705
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23781,61,1.07 [0.78-1.45],0.67816239222024
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23846,126,1.07 [0.86-1.32],0.5487105942834355
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23590,144,0.94 [0.75-1.18],0.5876683534130169
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23831,68,0.93 [0.66-1.30],0.6608912568063854
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23781,218,1.26 [1.10-1.44],0.0007091929396058
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23584,95,0.95 [0.72-1.25],0.7023579500989829
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23323,942,1.07 [0.99-1.15],0.1078414179702043
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23824,104,1.10 [0.87-1.38],0.4291329028215822
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23920,99,0.91 [0.69-1.22],0.537088656385397
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23478,229,1.09 [0.94-1.27],0.2525434857677845
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23756,36,0.85 [0.51-1.42],0.5350713035075683
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23917,34,0.91 [0.55-1.48],0.6913575346543858
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23282,33,0.64 [0.33-1.25],0.1896720654075333
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23351,102,1.07 [0.84-1.35],0.5963450987180414
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,23348,54,1.04 [0.74-1.47],0.8106650838589381
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23494,48,0.93 [0.63-1.38],0.7169424301604631
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",23340,46,0.90 [0.59-1.37],0.6163921003629704
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23609,46,1.18 [0.87-1.60],0.2894794354993012
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23640,77,1.30 [1.05-1.60],0.0165967316162525
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23323,74,1.20 [0.95-1.52],0.1309582251611317
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,23401,107,1.12 [0.90-1.38],0.3098535009285151
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,23324,30,1.16 [0.77-1.73],0.4802316337603487
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23098,717,0.96 [0.87-1.06],0.4304608960196747
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23293,44,1.15 [0.84-1.58],0.3908767167591584
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23750,261,0.88 [0.74-1.06],0.1758822304487965
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23520,31,0.84 [0.48-1.48],0.5524235144104055
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23599,110,1.06 [0.85-1.33],0.6051221223983163
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23760,55,0.98 [0.69-1.39],0.9085482007268492
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23899,81,0.98 [0.74-1.31],0.8962827878902067
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23830,123,0.82 [0.62-1.09],0.1718152278794423
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23754,49,1.22 [0.92-1.61],0.1757727677304713
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23757,52,1.19 [0.89-1.58],0.2337937731692306
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23857,468,1.00 [0.89-1.13],0.9655156316529574
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23675,286,1.08 [0.94-1.24],0.3002162661000452
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23477,88,1.26 [1.03-1.55],0.0263463380976527
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23455,66,0.88 [0.62-1.26],0.483191408116906
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,23679,69,0.73 [0.48-1.09],0.1261508622884296
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23825,215,0.94 [0.78-1.12],0.4766718718607283
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23669,59,0.92 [0.65-1.32],0.6609732137744662
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,All influenza,22826,67,1.07 [0.80-1.43],0.6531242200894186
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22825,66,1.05 [0.78-1.42],0.743874042982294
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),17711,117,1.26 [1.06-1.50],0.0102147761330872
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,23813,274,0.96 [0.82-1.13],0.6455891792981894
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18997,1537,1.03 [0.97-1.10],0.3775433215571484
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",19101,1507,1.02 [0.96-1.09],0.5625205715561766
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23696,84,1.29 [1.05-1.59],0.0134858027972159
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22808,49,1.43 [1.13-1.80],0.0027543531739892
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Bronchiectasis,21283,153,0.79 [0.60-1.03],0.076317227969669
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",21164,34,0.89 [0.54-1.48],0.6557105190264129
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23177,2047,1.03 [0.98-1.09],0.253973274304473
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22648,59,1.02 [0.74-1.41],0.899773480255171
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22730,141,1.14 [0.95-1.37],0.1562971884805193
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23851,630,1.04 [0.94-1.14],0.4814861502740717
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22707,118,0.98 [0.77-1.25],0.8798254129692347
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22257,3686,1.00 [0.96-1.05],0.8907098786390653
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22925,336,0.99 [0.86-1.14],0.8638618537023645
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Early onset COPD,23666,445,1.02 [0.90-1.14],0.7981116147641537
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Emphysema,21293,163,1.14 [0.95-1.36],0.1557079147857216
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22815,99,0.94 [0.72-1.24],0.6746478332807017
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23783,1024,1.05 [0.98-1.14],0.1746104244608711
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22837,121,0.88 [0.68-1.15],0.3491641369351635
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Later onset COPD,22674,185,1.07 [0.90-1.28],0.4208896840061039
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23933,131,0.79 [0.59-1.05],0.1020240576481487
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Nasal polyp,22691,102,0.84 [0.62-1.13],0.247916645422165
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23748,550,1.05 [0.95-1.16],0.3596541262708448
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,23783,1089,1.02 [0.94-1.10],0.6496530071791768
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23368,779,1.00 [0.91-1.09],0.9753035003045964
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Other pleural conditions,22726,32,0.84 [0.49-1.44],0.5229777657847812
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23888,177,0.93 [0.75-1.14],0.4728162712300615
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23866,738,1.02 [0.93-1.12],0.629859504497155
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Pleural effusion,23217,523,1.01 [0.90-1.13],0.8919293795445054
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Pleural plaque,22742,48,1.19 [0.88-1.62],0.2572693020131232
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23600,841,1.02 [0.94-1.11],0.6351275710665045
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23917,115,0.81 [0.60-1.09],0.1605249043963131
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Pneumothorax,22750,56,1.00 [0.71-1.40],0.9851746473712087
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Pollen allergy,23910,235,0.91 [0.76-1.09],0.3182212774705887
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,23746,35,0.96 [0.61-1.51],0.8619471564175052
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,17627,33,0.91 [0.55-1.49],0.7064114881607495
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23728,530,1.04 [0.94-1.16],0.4525575304786809
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22863,274,0.96 [0.82-1.13],0.6454675669469849
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Viral pneumonia,22921,162,1.13 [0.94-1.35],0.1898704545966615
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23711,140,1.10 [0.90-1.34],0.3518541563655147
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13802,86,1.16 [0.92-1.47],0.2016692858135629
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18326,57,1.02 [0.73-1.42],0.9200764438980722
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Acute appendicitis,23763,131,1.10 [0.91-1.34],0.3183373508115589
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Acute gastritis,19122,62,1.22 [0.94-1.57],0.1298623934305964
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,22535,149,1.26 [1.07-1.47],0.0047985837788318
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Acute peritonitis,23549,58,0.86 [0.58-1.28],0.4579759759467456
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23269,76,1.32 [1.06-1.64],0.0114658187219222
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,19366,306,1.01 [0.88-1.17],0.8563072346245469
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22433,47,1.20 [0.89-1.63],0.2265494095998726
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23593,47,1.20 [0.89-1.62],0.2385720900466831
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Cholecystitis,22539,153,1.20 [1.01-1.42],0.0350543705229926
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Cholelithiasis,23215,829,1.07 [0.99-1.16],0.0984253307422269
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Chronic gastritis,19274,214,1.07 [0.91-1.26],0.4037903081287568
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22422,36,0.83 [0.50-1.39],0.4859965489080794
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23811,76,1.32 [1.07-1.63],0.0099731485590138
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Coeliac disease,22696,94,1.32 [1.11-1.58],0.0020526387504486
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Collagenous colitis,22579,43,1.13 [0.81-1.57],0.4709691141931136
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23773,181,1.07 [0.90-1.27],0.4673649956989451
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Constipation,23744,1010,0.97 [0.89-1.05],0.4630912125471952
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Crohn disease,22612,76,0.94 [0.69-1.29],0.703896201056756
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23639,50,0.91 [0.61-1.36],0.6577765946109959
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22609,73,1.00 [0.75-1.35],0.9784605323050394
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Dental caries,23217,229,1.03 [0.88-1.21],0.7200001735420527
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22112,1554,0.99 [0.93-1.06],0.799412424034643
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of appendix,23801,169,1.08 [0.91-1.29],0.3799198127835752
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of liver,23833,640,1.10 [1.01-1.21],0.030768436245014
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22413,3353,1.01 [0.96-1.05],0.7658926185778246
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23515,527,1.09 [0.99-1.21],0.0743904076400859
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23863,372,1.07 [0.95-1.21],0.2742908747675329
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23098,110,0.88 [0.66-1.16],0.354574352999902
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22962,58,1.13 [0.85-1.51],0.3827574101487934
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23692,1090,1.04 [0.97-1.12],0.2547694156256756
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of tongue,22968,106,1.09 [0.87-1.36],0.4520100269523253
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23497,1111,1.06 [0.99-1.14],0.0937988764529523
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20379,2110,1.01 [0.96-1.07],0.7031175401811374
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,19188,128,1.14 [0.94-1.39],0.1939185023881723
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23874,100,1.20 [0.97-1.48],0.0939933247342041
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23824,71,1.04 [0.79-1.38],0.7818718391557979
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23286,93,1.23 [1.00-1.52],0.0526602525290249
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18425,156,1.05 [0.87-1.28],0.6115254610706219
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,19507,447,1.00 [0.88-1.12],0.95053524894339
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Gastric ulcer,19312,252,1.08 [0.93-1.25],0.3020905250666713
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21018,1958,0.97 [0.92-1.03],0.3480678622676345
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19425,365,1.09 [0.96-1.23],0.1838125887971534
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19472,6942,1.02 [0.99-1.05],0.1706621468648926
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,GI-bleeding,23478,876,1.04 [0.96-1.13],0.3318743767386585
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,23047,59,1.25 [0.98-1.60],0.0678574351073794
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,19056,1104,0.98 [0.91-1.06],0.6452543693882125
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23237,44,1.04 [0.71-1.53],0.831517402996345
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Hernia,22912,2354,0.99 [0.94-1.04],0.6959111549166932
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Impacted teeth,23833,66,1.01 [0.75-1.37],0.9493859074617972
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Impaction of intestines,18301,32,0.99 [0.64-1.53],0.949121489436536
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Inguinal hernia,21154,596,1.02 [0.92-1.13],0.7186423323589097
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",20629,71,1.04 [0.77-1.40],0.8108652318986851
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,18329,60,1.17 [0.89-1.52],0.2548029660090484
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22716,114,1.24 [1.04-1.48],0.0180149798006746
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18765,496,1.04 [0.93-1.16],0.4867108747568758
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23915,332,1.04 [0.91-1.20],0.5251761187856134
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23140,604,1.03 [0.93-1.14],0.5506095356614349
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23295,759,1.02 [0.93-1.11],0.7038622941103403
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19185,125,0.92 [0.71-1.18],0.5079239395225146
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Oesophagitis,19481,421,1.04 [0.93-1.18],0.4886063132666342
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23901,116,0.97 [0.77-1.24],0.8316787890929942
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20601,43,1.01 [0.69-1.48],0.9655179579709782
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19397,1128,0.97 [0.89-1.05],0.4016173770259135
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22555,169,1.01 [0.83-1.23],0.8915624752128131
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22526,140,1.23 [1.04-1.45],0.0136366199841429
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,19584,1315,0.97 [0.90-1.04],0.362642631204449
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,22490,4221,0.99 [0.95-1.03],0.5597629453032786
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22967,166,1.03 [0.86-1.24],0.7329030576796689
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of liver,23708,515,1.11 [1.00-1.22],0.0500363183311988
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19529,469,0.98 [0.87-1.10],0.7143785866064897
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22460,74,1.05 [0.79-1.39],0.7575380729365684
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23818,327,1.13 [1.00-1.28],0.0483438536582693
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19727,667,0.97 [0.88-1.08],0.6168130549264498
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23490,888,1.04 [0.95-1.12],0.4111254319252744
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23134,146,1.12 [0.93-1.35],0.2256559908232228
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19321,1052,0.96 [0.88-1.04],0.3038324375184146
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),20592,1532,1.00 [0.94-1.07],0.999372145443408
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23263,70,1.11 [0.85-1.46],0.4508013571364567
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23196,660,1.04 [0.95-1.14],0.4143363261527828
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18476,207,0.98 [0.82-1.17],0.7920239267475506
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23808,83,0.99 [0.75-1.30],0.9190449174220748
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18572,303,0.95 [0.81-1.10],0.4810296315506671
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22723,121,0.85 [0.64-1.12],0.2394375234874722
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23930,53,1.29 [1.00-1.65],0.0465534100095927
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22999,112,1.34 [1.14-1.58],0.0003307794211978
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Toxic colitis,22558,22,0.78 [0.39-1.57],0.4911303715964977
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19230,170,0.94 [0.76-1.16],0.5377568260553623
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,22666,130,0.84 [0.65-1.10],0.208669284179146
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22649,113,0.80 [0.59-1.08],0.150004503619646
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Umbilical hernia,20793,235,0.86 [0.70-1.04],0.1248062235105561
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,18361,92,0.96 [0.73-1.26],0.7591847287267702
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Ventral hernia,20761,203,0.96 [0.79-1.16],0.6549307022618969
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Volvulus,18325,56,0.94 [0.66-1.34],0.7289042324851003
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23899,136,1.15 [0.96-1.39],0.1216187919122562
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23708,74,0.96 [0.71-1.31],0.8110435588152332
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22668,133,0.82 [0.62-1.07],0.1376267570037094
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23385,484,1.13 [1.02-1.25],0.0212753766491488
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23080,179,1.06 [0.88-1.27],0.5383237615656844
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22684,149,1.00 [0.81-1.23],0.9715003081761098
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23714,201,1.07 [0.91-1.26],0.3937449054701047
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23854,341,1.04 [0.92-1.19],0.5108160740273662
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23552,39,1.15 [0.81-1.62],0.4293726781944265
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22676,2242,0.99 [0.94-1.05],0.7489885405013615
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23539,377,0.90 [0.78-1.05],0.1742592331736445
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23426,264,0.89 [0.74-1.06],0.1850091281863448
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23599,698,1.11 [1.02-1.21],0.0126254818041249
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23928,42,0.96 [0.64-1.43],0.8428255431222977
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,22590,55,0.71 [0.45-1.14],0.1608060996522416
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23200,38,1.02 [0.68-1.53],0.9175617060752952
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23708,195,1.06 [0.90-1.26],0.4796124920872662
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22789,254,1.02 [0.88-1.20],0.7554842000999101
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,22567,32,0.44 [0.19-1.01],0.0521785043063769
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23865,65,0.94 [0.67-1.32],0.739596552975748
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,23018,117,1.02 [0.80-1.28],0.8919600507511498
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23764,130,0.91 [0.71-1.16],0.4395680135842554
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23537,24,1.09 [0.67-1.76],0.7285106994717356
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,22581,46,0.73 [0.43-1.22],0.2243463770198371
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23497,962,0.95 [0.87-1.04],0.2619795558734116
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22819,284,1.03 [0.89-1.19],0.6720624134355426
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,22571,36,0.42 [0.19-0.94],0.0335678442540491
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23870,236,0.89 [0.74-1.07],0.2234326373338742
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23567,54,1.04 [0.75-1.45],0.8065216761925424
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23826,192,0.90 [0.73-1.10],0.2923972386951435
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23913,150,1.13 [0.95-1.35],0.1702825315345977
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22647,112,0.66 [0.46-0.93],0.0174598547091409
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22696,161,0.97 [0.79-1.19],0.7520525704639096
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23907,144,1.13 [0.95-1.36],0.1746044499166886
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",22648,113,1.17 [0.96-1.44],0.1225500565835762
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23908,108,1.01 [0.79-1.29],0.9358499038749136
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20970,117,1.05 [0.84-1.31],0.6494499119019921
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22313,4040,1.01 [0.97-1.05],0.5210822558018302
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,21139,2866,1.00 [0.96-1.05],0.9164096582924682
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20937,84,1.09 [0.85-1.40],0.499778669005895
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21457,137,1.01 [0.81-1.25],0.9636734855040044
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21465,145,1.02 [0.83-1.25],0.8397384673944243
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23733,105,0.69 [0.49-0.98],0.0388453707408973
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",21361,41,0.59 [0.31-1.11],0.103425864489996
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18931,658,0.99 [0.90-1.10],0.9184512862514144
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23882,113,0.81 [0.60-1.09],0.1663746332879316
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21567,247,1.11 [0.96-1.28],0.1574718548945113
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20904,5427,1.01 [0.98-1.04],0.5983055489128617
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22717,101,0.76 [0.54-1.06],0.1056421359025177
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20959,106,1.03 [0.81-1.31],0.8196283929544077
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21396,543,0.99 [0.89-1.11],0.9207827435353976
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23163,1843,1.02 [0.97-1.09],0.4028612926726096
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,21056,203,0.96 [0.79-1.15],0.6474579594619961
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,21110,257,0.96 [0.81-1.13],0.6178430169494633
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20989,136,1.03 [0.84-1.27],0.7770889750023856
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23472,34,0.48 [0.22-1.03],0.0582563850386853
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19402,1129,0.99 [0.92-1.07],0.7803887925813988
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18608,335,1.18 [1.05-1.32],0.0059070264899154
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23891,326,1.17 [1.03-1.32],0.0138143202163782
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18338,65,1.12 [0.85-1.47],0.4174565562940064
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18576,303,1.08 [0.95-1.23],0.2558492369802909
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21138,285,1.05 [0.91-1.21],0.4888367637805882
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18943,670,1.02 [0.93-1.13],0.653764828299586
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,21344,24,0.88 [0.48-1.59],0.6646613347791249
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21814,494,0.92 [0.81-1.05],0.2064661581781653
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21573,253,1.04 [0.89-1.22],0.5982282860833301
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18895,622,1.03 [0.93-1.13],0.6214763915120021
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20922,69,0.79 [0.54-1.17],0.240165011049008
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20907,54,0.95 [0.66-1.36],0.7660124333374246
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22670,54,1.09 [0.79-1.51],0.5903301459652843
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23650,1034,0.97 [0.89-1.05],0.4389230657231537
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23201,585,0.97 [0.87-1.08],0.5851672197831574
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23836,305,0.92 [0.78-1.08],0.2974934735500367
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19833,1560,1.02 [0.96-1.08],0.5737900225304664
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18338,65,1.23 [0.96-1.56],0.0977579724610656
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20921,68,1.12 [0.85-1.46],0.4169472628839384
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18299,26,1.21 [0.82-1.79],0.3399053922824863
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18374,101,1.12 [0.90-1.39],0.3192683270347224
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22828,212,0.93 [0.77-1.12],0.4322932380086424
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22832,216,1.05 [0.89-1.24],0.5573258256860477
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23904,75,0.88 [0.63-1.23],0.4464444591771593
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22706,1386,1.01 [0.94-1.08],0.8512683602114394
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20962,109,1.12 [0.91-1.38],0.2960739829483334
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18385,112,1.07 [0.86-1.33],0.5261884306923232
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21874,554,1.05 [0.95-1.17],0.3185267194187726
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20063,1790,1.00 [0.94-1.06],0.947863419615264
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23488,50,0.60 [0.34-1.05],0.0716541523231616
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23918,69,1.02 [0.76-1.37],0.9111970290743392
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20922,69,1.01 [0.75-1.37],0.9264302521945328
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21819,966,1.01 [0.93-1.10],0.8011785951151666
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20914,61,1.09 [0.82-1.46],0.5551463495392237
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19257,984,1.02 [0.94-1.10],0.6461492936753261
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22713,97,1.02 [0.80-1.31],0.847115833531286
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20911,58,0.88 [0.60-1.29],0.5082929281750646
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,21423,103,0.97 [0.75-1.26],0.8124645993532382
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21201,348,1.01 [0.88-1.15],0.9250177178195246
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23624,186,0.95 [0.78-1.15],0.5998434909601298
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21740,420,1.04 [0.92-1.17],0.5768165473761909
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23843,290,0.91 [0.77-1.07],0.2672117505769514
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23924,34,1.22 [0.86-1.71],0.2628071268695758
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,21033,180,0.99 [0.82-1.20],0.9378577326244968
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19191,534,0.95 [0.84-1.07],0.3779442235112792
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21286,433,1.02 [0.90-1.15],0.7522678355638562
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],21003,150,1.02 [0.84-1.25],0.8158208387019942
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18307,34,0.96 [0.61-1.50],0.8431738736120183
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19821,1548,1.02 [0.95-1.08],0.6307614079861613
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18670,397,0.99 [0.87-1.13],0.9271654099940816
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23513,75,1.04 [0.78-1.37],0.8048139542275448
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23873,44,0.94 [0.62-1.41],0.7545280193172429
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",22548,26,1.11 [0.71-1.73],0.6551195764567465
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18344,71,1.01 [0.75-1.36],0.943118049428428
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,21404,84,1.23 [0.99-1.53],0.0634120068705139
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18582,309,0.97 [0.84-1.13],0.7000431819179977
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,21092,239,1.12 [0.97-1.30],0.1226452253128874
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21508,188,1.06 [0.89-1.27],0.4800845719960466
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,21410,90,1.16 [0.92-1.45],0.2088434781798168
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,20242,43,0.90 [0.58-1.38],0.61881491962573
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23927,37,1.23 [0.89-1.70],0.2015137984545927
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21377,524,1.07 [0.97-1.19],0.1835733558015674
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],23516,78,0.87 [0.63-1.21],0.4099678415836358
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22990,2137,1.02 [0.97-1.08],0.405209154043
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20953,100,0.98 [0.76-1.27],0.8932842043480641
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21632,312,1.20 [1.06-1.35],0.0026887141088847
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22705,167,1.09 [0.91-1.30],0.3697699693448818
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,21449,129,1.16 [0.96-1.41],0.1252260573246963
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22254,934,1.06 [0.98-1.15],0.1213232198233989
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21933,613,1.09 [0.99-1.20],0.0696984534107547
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20892,39,1.30 [0.97-1.74],0.0819786415010837
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23576,138,1.18 [1.00-1.40],0.0559232268496398
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20990,137,0.96 [0.77-1.21],0.7402900388146303
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20906,53,1.16 [0.87-1.55],0.3205801933484919
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18305,32,1.06 [0.70-1.62],0.7700784457262579
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,23492,734,1.10 [1.01-1.20],0.0216710638584198
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9697,64,0.78 [0.53-1.15],0.2130159769180207
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,12911,70,1.03 [0.78-1.36],0.847373995720402
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23683,271,0.93 [0.78-1.10],0.3802349615499806
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23468,56,0.75 [0.47-1.19],0.2247699470715751
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23308,550,1.01 [0.91-1.13],0.8582912605107909
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23786,19,0.67 [0.29-1.58],0.3608333282508008
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23793,163,1.11 [0.92-1.32],0.2783298700294541
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Cystitis,21987,133,1.17 [0.98-1.40],0.0868214657719835
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Dialysis,22799,41,1.05 [0.72-1.53],0.807671301043978
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10359,973,0.92 [0.84-1.01],0.0860621627391
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,13013,172,1.02 [0.85-1.22],0.8504367911008155
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,9747,114,0.88 [0.68-1.13],0.3101869224321169
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",9970,337,0.99 [0.87-1.13],0.8884706667824597
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,10014,381,0.92 [0.80-1.06],0.2565291510174349
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20188,3679,1.00 [0.96-1.04],0.984156419648654
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23822,55,1.14 [0.85-1.53],0.3648477914821779
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,9453,67,0.94 [0.67-1.32],0.7312459799727116
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,22676,192,0.94 [0.77-1.15],0.541831990821358
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,10040,654,0.96 [0.86-1.06],0.4199028505822887
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12903,206,1.05 [0.90-1.23],0.5264704477269617
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9477,91,0.85 [0.62-1.17],0.3190627386221063
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,12912,109,0.77 [0.57-1.03],0.0825109655021563
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,9896,263,1.03 [0.90-1.18],0.6695252629360977
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21908,54,0.80 [0.52-1.23],0.3058842899267826
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10868,1235,1.00 [0.94-1.07],0.9282884782748628
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,9431,45,0.90 [0.58-1.39],0.6272172328199459
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9718,85,0.95 [0.72-1.25],0.7094108119520243
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23930,35,1.07 [0.72-1.60],0.7417809208276287
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23935,38,1.06 [0.72-1.55],0.7611999868782718
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23182,1328,1.00 [0.94-1.07],0.9431250272980508
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22267,413,0.99 [0.87-1.12],0.8375299868981204
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,12896,55,1.03 [0.75-1.41],0.8553390547837927
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23893,263,1.08 [0.94-1.25],0.2886532132824703
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9523,137,0.98 [0.78-1.23],0.8427213568855935
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9488,102,0.86 [0.63-1.16],0.3203565894605464
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,9452,66,0.70 [0.45-1.10],0.124346317432854
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23907,47,1.42 [1.12-1.79],0.00324221187832
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22828,974,0.98 [0.91-1.07],0.7182073723275115
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,12804,107,0.92 [0.71-1.19],0.5020269722732071
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9706,73,0.95 [0.70-1.29],0.7567847187692878
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9840,207,1.02 [0.86-1.20],0.8523531527154532
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9686,53,0.91 [0.63-1.33],0.6354741973348995
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9724,91,1.08 [0.85-1.37],0.5315577909474559
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22705,221,0.99 [0.83-1.17],0.8703148587791605
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23718,88,1.13 [0.89-1.43],0.3298429244592731
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9790,157,1.13 [0.96-1.33],0.1453977125597208
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9701,68,1.03 [0.78-1.36],0.8564132240604482
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10003,370,0.93 [0.81-1.06],0.280191712551158
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9689,56,0.87 [0.59-1.28],0.4731188696696388
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9965,332,0.97 [0.84-1.11],0.640988601381322
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23806,39,0.97 [0.64-1.47],0.8795755639998786
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9474,88,0.73 [0.50-1.06],0.1003344227094611
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23782,1298,1.03 [0.96-1.11],0.357229187790549
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",22610,126,0.95 [0.75-1.20],0.6698486914591257
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22815,57,1.17 [0.89-1.54],0.2561497109004986
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23472,60,1.06 [0.77-1.45],0.7271180213682326
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,22006,152,0.98 [0.79-1.21],0.8474952640342153
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23740,328,0.94 [0.80-1.09],0.4106416887876946
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9718,85,1.05 [0.82-1.34],0.6932702441622629
